J&J wins FDA approval for dual-energy ablation catheter

Johnson & Johnson received FDA approval for a dual-energy ablation catheter device, with U.S. physicians expected to perform initial procedures in summer 2026 as part of a phased commercial rollout. The device represents a new advancement in cardiac ablation technology.